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Objectives: Successful carotid artery stenting (CAS) involves gaining access to the common carotid artery, characterizing
and crossing the lesion, deploying an anti-embolic device and stent, and retrieving the anti-embolic device. These steps are
critical determinants of the complexity of the procedure. The frequency with which technical challenges are encountered
during CAS is ill-defined. The purpose of this investigation was to review the incidence and types of technical challenges
encountered during CAS and determine their effect on outcome.
Methods: Data were prospectively collected for 194 consecutive CAS procedures (177 patients) and separated into group
1, standard CAS technique, and group 2, procedures with technical challenges requiring modifications to the technique.
Technical challenges were defined as difficult femoral arterial access (aortoiliac occlusive disease), complex aortic arch
anatomy (elongated or bovine arch, deep takeoff of the innominate artery, tandem stenoses (CCA, innominate artery),
difficult internal carotid artery anatomy (tortuosity, high-grade stenosis), and circumferential internal carotid artery
calcification. The incidence of technical challenges, types of technical modifications required, and effect on outcomes were
determined.
Results: Fifty technically challenging situations (26%) were encountered in 194 CAS procedures (group 2), which required
advanced technical skills. Standard methodols were used in the other 144 procedures (group 1, 74%). No significant
differences in 30-day stroke and death rates were noted between the groups (group 1, 3.1%; group 2, 2.0%; P  .564).
Conclusions: Twenty-six percent of the procedures required a modification in the standard technique for successful CAS.
Circumferential calcification and severe tortuosity continue to be relative contraindications to CAS. Recognition of these
technical challenges and increasing facility with the methods to manage them will enable expanded use of CAS without
increased morbidity and mortality. ( J Vasc Surg 2004;40:746-51.)Data from prospective randomized trials have con-
firmed the efficacy of carotid endarterectomy (CEA) to
treat symptomatic1-3 and asymptomatic4,5 carotid occlu-
sive disease. As a potentially less invasive alternative, carotid
artery stenting (CAS) is currently being investigated in
randomized clinical trials in patients at high risk6 and good
risk.7-10 However, subsets of patients, including those with
recurrent stenosis, anatomically high carotid lesions, his-
tory of neck irradiation, and severe medical comorbid con-
ditions, may benefit from CAS,11 and are currently being
managed with these techniques.
The Society for Vascular Surgery has published current
minimal catheter and guide wire skills for vascular surgeons
for performance of interventional procedures.12 However,
the Society has not defined the minimal requirements nec-
essary for the performance of CAS. CAS requires advanced
skills as well as clinical judgment in the selection of patients.
We have documented our recommended procedural out-
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doi:10.1016/j.jvs.2004.07.021746line for CAS.13,14 However, modified techniques are fre-
quently required, which prompted a review of our clinical
series.
METHODS
Performance of CAS at our institution was initiated by
a team of vascular surgeons and cardiologists in 1996.
During the period September 1996 to March 2004, 194
consecutive CAS procedures were performed in 177 pa-
tients. Indications for CAS included high-grade carotid
recurrent stenosis after previous CEA in 110 patients
(57%); high risk in patients with medical comorbid condi-
tions, as previously defined by our group,15 in 53 patients
(27%); radiation-induced stenoses in 13 patients (7%); pa-
tients at normal risk with symptomatic stenosis randomized
to CAS in 9 instances (4.5%); in-stent recurrent stenosis in
6 patients (3%); and anatomically high bifurcation in 3
patients (1.5%). Asymptomatic stenoses were stented in
128 patients (66%), and symptomatic lesions in 66 patients
(34%). This cohort of patients included 99 men (56%) and
78 women (44%), with mean age of 71 years (range, 45-93
years).
CAS protocol. CAS was performed with modifica-
tions as described.13,14 Patients received pretreatment with
aspirin and clopidogrel. Combined antiplatelet medication
was continued for a minimum of 4 weeks after CAS, and
aspirin therapy alone thereafter. Procedures were per-
formed in the awake patient with local anesthesia for the
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mal intravenous sedation.
Standard retrograde access was performed in the com-
mon femoral artery, and a 6F vascular sheath (Cordis) was
inserted. Aortic arch angiography was generally performed
with a 5F pigtail catheter (Cook). Weight-adjusted heparin
was administered (60 U/kg), with activated clotting time
maintained at 225 to 300 seconds throughout the proce-
dure. A 0.035-inch, 145-cm Wholey modified guide wire
(Mallinckrodt) in a 5F Vitek catheter (Cook) was intro-
duced for selective cannulation of the common carotid
artery (CCA). The Wholey guide wire was commonly ex-
changed for a 0.035-inch, 260-cm Connors guide wire
(Meditech/Boston Scientific) for advancement of the Vitek
catheter into the CCA and a 6F 90cm length Raabe sheath
(Cook Inc.) was advanced over the Vitek and Connors
guide wire into the CCA. Digital angiography was per-
formed to confirm the severity of carotid stenosis, and
pre-procedural cerebral angiograms were also obtained at
this time. The stenoses were crossed with anti-embolic
devices (AED) mounted on a 0.014-inch wire with deploy-
ment of the AED in the internal carotid artery (ICA), distal
to the stenosis. An ACCUNET (Guidant) anti-embolic
filter device was used in all cases in which the ACCULINK
stents (Guidant) were used. A Filterwire (Boston Scientific)
or PercuSurge Guardwire (Medtronics) was used in cases in
which Wallstents (Boston Scientific) were delivered. The
stent was treated with post-deployment angioplasty with 5
to 5.5  20-mm Ultra-soft balloons (Boston Scientific)
inflated to 8 to 10 atm. A completion angiogram was
routinely obtained, and the AED was re-sheathed and
removed. Ipsilateral cervical and intracranial carotid an-
giography was performed to assess technical success and to
exclude distal cerebral embolization. Post-procedure, pa-
tients were monitored in an intermediate care unit over-
night, and duplex ultrasound scanning of the cervical ca-
rotid artery and stent was performed the following
morning, with subsequent discharge thereafter.
Modified procedural techniques. Procedures were
categorized according to the above protocol (group 1, n
144) or modified (group 2, n  50) on the basis of
assignment to 1 of 6 clinical categories (Table). Technical
Table I. Technical challenges and required modifications
Technical challenges
Category Description n
1 High-grade stenosis 24
2 Complex aortic arch anatomy 12
3 Difficult femoral artery access 7
4 Tandem stenotic lesions 3
5 Circumferential calcification 2
6 Internal carotid artery tortuosity 2
CCA, Common carotid artery; CEA, carotid endarterectomy.modifications were documented, and results for groups 1
and 2, including 30-day stroke and death rates, were as-
sessed for statistical significance with the Fisher exact test.
Category 1. Category 1 included high-grade (80%-
90%; minimal lumen diameter 1.0 mm) stenosis that
precluded passage of the AED (n  24). The ICA stenosis
was crossed with an 0.014-inch high-torque floppy
“buddy” wire (Cordis), and predilation was performed
with a 2.5-mm or 3-mm low-profile coronary balloon
(Boston Scientific). The stenosis was then crossed with the
AED using the buddy wire to assist its passage. The 0.014-
inch high-torque floppy wire was then removed, and the
AED deployed.
Category 2. This category included complex aortic
arch anatomy, bovine configuration, or more proximal
origin of the innominate artery (type 3) (n 12). The CCA
or innominate artery was cannulated with a 5F 100-cm
JB-2 (Boston Scientific), 5F 100-cm Berenstein (Cordis),
or 5F 100-cm Simmons-2 (Boston Scientific) catheter.
Category 3. This category included patients with
compromised femoral access (n  7). Three patients un-
derwent treatment with transbrachial techniques, and 4
patients with direct surgical exposure of the CCA. Brachial
artery exposures were performed in the cardiac catheteriza-
tion laboratory with use of local anesthesia. Carotid expo-
sures were performed with local anesthesia, with placement
of a 6F vascular sheath by means of standard techniques in
the operating room with C-arm technology. Brachial artery
exposure and access was obtained ipsilateral to the carotid
stenosis in 2 patients, and brachial arterial access was ob-
tained contralateral to the carotid stenosis in a third patient.
An arteriotomy was made in the brachial artery, and an 8F
sheath was inserted. A Wholey wire over a 7F LIMA
catheter (Cordis) was used to access the ipsilateral CCA in
2 patients, and a 5F Vitek catheter (Cook) was used to
cannulate the CCA in the contralateral case. AEDs could
not be safely placed in these patients, because of arterial
tortuosity. Two balloon-mounted stents (Genesis; Boston
Scientific) were placed, and 1 Wallstent (Boston Scientific)
was placed to cover ICA stenoses.
Category 4. This category included tandem stenoses
(n  3). Patients with tandem stenoses (Fig 1, A and B)
rformance of carotid artery stenting
Technical modifications
Technical
challenges (%) Description n
48 Buddy wire with predilation 24
24 Alternative catheters 11
Direct CCA cutdown 1
14 Direct CCA cutdown 4
Transbrachial access 3
6 Multiple stents 3
4 Elective CEA 2
4 Elective CEA 1in pe
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underwent standard treatment, but 1 patient required a
cutdown because of a proximal CCA lesion, which was
treated in retrograde fashion with a Wallstent, and the
sheath was then adjusted anterograde for management of
the ICA stenosis with a second Wallstent.
Category 5. This category included ICA tortuosity (n
 2). One patient had greater than 90-degree angulation,
with redundancy of the ICA on pretreatment angiograms
(Fig 2). This resulted in cancellation of the CAS procedure
and performance of CEA with posterior wall plication and
synthetic patching. The other patient with tortuous anat-
omy on angiograms demonstrated a lesser degree of steno-
sis (40%), and is being observed with serial carotid duplex
ultrasound scans.
Category 6. This category included ICA circumferential
calcification (n2). One patient underwent CAS (Fig 3), and
was observed to have 40% residual stenosis on the post-
procedure angiogram. This stenosis progressed and became
associated with distal in-stent recurrent stenosis greater than
80% 6 months after CAS. CEA with removal of the stent and
patch angioplasty was performed. In the other patient circum-
ferential calcification was diagnosed at intraprocedural an-
giography, and the CAS procedure was terminated. This
patient underwent CEA preferentially.
RESULTS
The technical success rate for CAS was 98% (190 of
194). Procedures were canceled in 3 patients, and immedi-
ate CEA was performed because of tortuosity in 1 patient
and circumferential calcification in 1 patient. Three patients
underwent transbrachial CAS procedures successfully, and
Fig 2. Carotid angiogram demonstrates a tortuous internal ca-
rotid artery (ICA; arrow) in a patient with symptomatic high-
grade stenosis.Fig 1. A, Selective carotid arteriogram confirms tandem stenoses
(arrows) in the common carotid artery (CCA) and internal carotid
artery (ICA) in a patient with a history of neck irradiation. B, Com-
pletion arteriogram after placement of stents in the CCA and ICA.
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exposure. Advanced interventional techniques were re-
quired in 26% of our procedures (50 of 194), and the
technical modifications necessary are summarized in the
Table.
One patient in group 1 died suddenly of an apparent
acute myocardial infarction 10 days after discharge, and a
second patient died after evacuation of a retroperitoneal
hematoma complicated with fatal intracranial hemorrhage
2 days after CAS. Two non-disabling strokes also occurred
in group 1; no strokes were observed in group 2. One
patient in group 2, with severe chronic obstructive pulmo-
nary disease, died of respiratory complications of pneumo-
nia and congestive heart failure 15 days after discharge after
CAS. There were no differences in 30-day stroke and death
rates between group 1 (4 of 127, 3.1%) and group 2 (1 of
50, 2%; P .564). Periprocedural stent thrombosis was not
observed. One patient required removal of the stent, be-
cause of in-stent recurrent stenosis accompanied by endar-
terectomy of the calcified plaque 6 months after the original
CAS procedure. Hematomas developed in 4 patients in
group 1. Two patients required operative repair, and the
other 2 patients required transfusions but nonoperative
management. One patient with a groin hematoma in group
2 required blood transfusion but not operative interven-
tion. Other medical complications, including transient bra-
dycardia and hypotension, were noted in fewer than one
third of patients, and were equally balanced between
groups, without contributing to more serious adverse
events. Contrast agent–induced renal failure did not occur
in either group.
Fig 3. Selective carotid angiogram demonstrates circumferential
plaque calcification in a patient with symptomatic high-grade
stenosis.DISCUSSION
Our program in CAS was initiated in 1996 through a
collaborative effort of vascular surgeons, neurologists, and
cardiologists. Initially our cases included primarily recur-
rent stenosis after previous CEA, and thereafter was ex-
panded to include other indications, such as radiation-
induced stenosis, anatomically high lesions above the
second cervical vertebra, and patients with more severe
medical comorbid conditions. While some smaller clinical
series, including our cases,16 have reported low complica-
tion rates in patients with recurrent stenosis after CEA,
collected data17 from multiple centers confirm a 30-day
stroke and death rate of 3.7% in 358 patients. These data are
comparable to complications reported in patients with ath-
erosclerotic stenosis, which emphasizes the importance of
applying our technical recommendations to all patients
undergoing CAS.
Review of our clinical experience with CAS demon-
strated that in 50 procedures (26%) technical modifications
to our usual protocol were required. Technical success was
achieved in 98% (190 of 194) of procedures, and no differ-
ences in 30-day stroke and death rates were noted between
the groups (group 1, 3.1%; group 2, 2.0%; P  .564).
Circumferentially calcified plaques and severe tortuosity
were identified as contraindications to CAS. These contra-
indications to CAS are based on anecdotal observations
from our clinical series, and will require further confirma-
tion by other clinicians. Data from this clinical series dem-
onstrate comparability with recently published results. Cre-
monesi et al18 reported a 1.1% stroke and death rate and a
99.5% technical success rate, and Wholey et al19 reviewed
the world experience by questionnaire and reported a
3.98% stroke and death rate, with a technical success rate of
98.9% in 12,254 cases.
The most commonly encountered technical challenge
was high-grade stenosis that impeded safe placement of an
AED (category 1). Although predilatation was used in
these cases to facilitate subsequent passage of AEDs, only 7
of 194 (3.6%) cases were managed without the recom-
mended placement of an AED. These devices are used
routinely in CAS, and mounting evidence supports their
use in all CAS procedures. While data were self-reported
from 53 centers, Wholey et al19 reported a 30-day stroke
rate of 3.22%, and death rate of 6.93%, in patients with
symptomatic disease, with and without cerebral protection.
Comparable data from patients with asymptomatic disease
were 2.51% and 4.78, respectively. A recent clinical alert
was posted by the EVA-3S investigators,20 because of
stroke and death rates that were 3.9 times higher without
cerebral protection in the early part of their trial, and
recommended avoidance of CAS in the absence of an AED.
While nearly half of our cases composed category 1, many
of our patients were managed in trial protocols that re-
quired use of specific AEDs. SAPPHIRE investigators did
not report as high an incidence of difficulty in placement of
AEDs. However, this may have been related to the lower
incidence of angiographically confirmed stenosis greater
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generation AED. Because the profile of AEDs decreases
from first-generation devices (generally 5F) to rapid ex-
change systems (generally 3.0F-3.7F), we anticipate a de-
crease in the number of these cases.
Complex aortic arch anatomy (category 2) was man-
aged with use of alternative catheters, which facilitated the
CAS procedures. Compromised femoral arterial access (cat-
egory 3) can be managed with alternative techniques when
transfemoral access cannot be achieved. Surgical exposure
of the CCA has been reported as a safe alternative.22 The
transbrachial exposure also has its proponents; however, its
performance precluded use of an AED in our patients,
which might increase complications in a larger series. How-
ever, Al-Mubarek et al23 reported using a distal balloon
occluder (Percusurge; Medtronics) during transbrachial
CAS. Other opportunities for successful CAS include the
transradial approach, as described by Levy et al.24
Tandem stenoses (category 4) were managed with mul-
tiple stents. While this required an alternative plan, the use
of 2 or 3 stents to cover extensive or tandem stenoses
appears to be well tolerated without increased complica-
tions.
Circumferential calcification and severe tortuosity (cat-
egories 5 and 6) of the carotid artery became contraindica-
tions for CAS in our series. This has also been documented
and reported by d’Audiffret et al.25 In their experience with
CAS, 2 patients required conversion to open endarterec-
tomy because of residual stenosis and kinking. Although
some case reports advocate use of CAS for kinked ICA,26
treatment with endarterectomy is recommended, particu-
larly when the tortuousity exceeds 90 degrees. Our experi-
ence with CAS in the presence of a circumferential calcified
carotid plaque resulted in unacceptable subsequent devel-
opment of in-stent recurrent stenosis. This patient ulti-
mately required endarterectomy. Another patient in our
recent experience has undergone CEA, and 2 additional
patients did not undergo CAS because of angiographically
observed circumferential calcification.
Basic catheter and guide wire skills are required before
learning techniques for CAS.13 These skills are possessed by
vascular surgeons who have separately acquired the skills or
have graduated from accredited fellowships in vascular sur-
gery. Cardiologists who have completed fellowships in
interventional cardiology are similarly able to proceed.
Further analysis of data from training programs will be
essential to confirm these impressions.
The appreciation of pathophysiologic features and non-
invasive diagnosis of carotid occlusive disease by our group
also contributed to our program’s success. While basic skills
are acceptable for performance of most CAS procedures,
advanced techniques are necessary to perform CAS in as
many as one fourth of patients. CAS in patients included in
these categories should be deferred if the operator is inex-
perienced or is initiating a program in CAS. However, as
these additional skills are acquired, CAS can be performed
without an increased incidence of complications.REFERENCES
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Submitted Apr 29, 2004; accepted Jul 13, 2004.DISCUSSIONDr Daniel B. Walsh (Lebanon, NH). The first question that
comes to my mind is, How many of these technical difficulties
could you anticipate prior to the procedure? It seems to me that
certainly tortuosity, calcification, those kinds of things, are readily
seen with preoperative duplex scanning.
Dr Hung M. Choi. All of our patients undergo preoperative
duplex scanning. We are now more vigilant, and can predict many
of these cases, especially tortuosity and calcification, as you men-
tioned, with preoperative duplex scanning or MRA.
Dr Sean D. O’Donnell (Washington, DC). I may have
missed. I didn’t see how many of your difficult cases were due to
type B or C arches. And I was wondering what you would suggest
in the way of guides or other techniques to deal with the type B and
C arch.
Dr Choi. In our series the bovine and type B or C arches
numbered 12, and constituted the second most common technical
challenge. For our standard cases, we used a Vitek-type catheter
and 0.035-inch Wholey or glide wire. However, for the more
difficult arches we have used a JB-2, Simmons, or Berenstein
catheter and an 0.035-inch Amplatz Connors wire. In our experi-
ence, these modifications in technique have helped facilitate can-
nulations and stent deliveries without increasing stroke risk.
Dr Manish Mehta (Albany, NY). Over the years we’ve cer-
tainly learned a lot from your institution regarding refining the
techniques of carotid stenting, so I think we all appreciate that.
There are a few technical points. We do things a little differ-
ently, and I think we can do it better on our end, so we needed your
input on that.
First, predilate, never predilate, or only predilate if needed?
Second, sizing the balloon to the lesion. You always have
poststenotic dilatation. We always run into trouble, saying, Do we
stay with the 4-mm balloon? Do we go to 4.5 mm? Do we go to 5
mm? Because it looks seductive. And we try to stay on the lower
end, just to avoid dissections and other problems. But I’m just not
sure what the right thing to do here is.
Third, do you guys use atropine routinely? If you don’t, at the
time of doing the angioplasty to maintain hemodynamic stability
and prevent bradycardia?
Fourth, I know you put a quarter by the neck. We used to do
similar things; we used to use a dime. I trained at Montefiore, andthat’s what Tak used to do. But there’s a graduate wire, and there
are other wires that have markers on them. I think that might help
with a more precise measurement, especially because there are a lot
of times that you need that.
And I know I’ve read your papers in the past, or papers from
your institution, about management of in-stent stenosis or recur-
rent in-stent stenosis, with angioplasty versus carotid endarterec-
tomy. And I wonder if you can comment on that. How do you
decide whether you’re going to try angioplasty again versus back
off? Is it the second time, the third time? And what’s your experi-
ence?
Dr Choi. To your first question, to pre-dilate or not, with the
first-generation anti-embolic devices, we generally have pre-di-
lated. These anti-embolic devices have profiles that exceed 5F.
However, the newer devices, the filter wire and the new generation
ACCUNET for example, are in the 3.0F to 3.5F side, and have
generally not required pre-dilation prior to placement of an anti-
embolic device.
Your second question was about the poststent angioplasty. We
also tend to undersize angioplasty balloons. However, we generally
use 5.0-mm to 5.5-mm balloons, and stay within the confines of
the stent to prevent dissection. In so doing, we have not observed
arterial disruptions or dissections.
Third, we generally administer atropine (0.5-1.0 mg IV) prior
to use of balloon angioplasty or stent deployment when bradycar-
dia or hypotension occasionally are observed. A reference diameter
is useful, and a coin taped to the neck or the 6F sheath are
commonly used for this purpose.
And your last question was regarding recurrent stenosis. Gen-
erally, in-stent recurrent restenosis (80%) is managed with bal-
loon angioplasty. Our experience was previously documented [J
Vasc Surg 2003;38:1162-9]. Life table analysis predicted in-stent
recurrent stenosis greater than 80% in 6.4% of patients at 60
months. Repeat angioplasty was performed once in 3 patients, 3
times in 1 patient, and angioplasty with repeat stenting in 1 patient,
without complications. As can be seen from our review, most
instances of in-stent recurrent stenosis occur early after CAS, and
can be managed successfully with endovascular techniques.
